Role of Y Box Protein-1 in cancer: As potential biomarker and novel therapeutic target

The Y-box binding protein (YB-1) is known to be a multifunctional transcription and translation factor during expression of several proteins. It is a vital oncoprotein that regulates cancer cell progression and proliferation. YB-1 is over-expressed in various human cancers such as breast cancer, col...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Cancer Jg. 8; H. 10; S. 1900 - 1907
Hauptverfasser: Maurya, Pramod Kumar, Mishra, Alok, Yadav, Birendra Singh, Singh, Swati, Kumar, Prashant, Chaudhary, Amit, Srivastava, Shweta, Murugesan, Suriya Narayan, Mani, Dr. Ashutosh
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Australia Ivyspring International Publisher 01.01.2017
Schlagworte:
ISSN:1837-9664, 1837-9664
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The Y-box binding protein (YB-1) is known to be a multifunctional transcription and translation factor during expression of several proteins. It is a vital oncoprotein that regulates cancer cell progression and proliferation. YB-1 is over-expressed in various human cancers such as breast cancer, colon cancer, lung cancer, gastric cancer oesophageal cancer and glioblastoma. Nuclear expression of YB-1 is found to be associated with multidrug resistance and cancer cell progression. YB-1 is reported to regulate many cellular signalling pathways in different types of cancer proliferation. Knowledge about nuclear localization and nuclear level expression of YB-1 in different cancers has been correlated with prospective prognosis of cancer. This review discusses the prospects of YB-1 as a potential biomarker as well as therapeutic target in lieu of their role during cancer progression and multidrug resistance.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Competing Interests: Authors declare no conflicts of interest.
ISSN:1837-9664
1837-9664
DOI:10.7150/jca.17689